Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma.
Berns
A J
AJ
Somatix Therapy Corporation, Alameda, CA 94501, USA.
Clift
S
S
Cohen
L K
LK
Donehower
R C
RC
Dranoff
G
G
Hauda
K M
KM
Jaffee
E M
EM
Lazenby
A J
AJ
Levitsky
H I
HI
Marshall
F F
FF
D000818:Animals; D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000556:secondary* / Q000628:therapy*; D017690:Cell Transplantation; D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic; D015316:Genetic Therapy; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics* / Q000494:pharmacology; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D014161:Transduction, Genetic; D014182:Transplantation, Autologous; D014407:Tumor Cells, Cultured
D016178:Granulocyte-Macrophage Colony-Stimulating Factor